Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rocket Doctor AIAIRDF -1.16%29 Earnings per Share (Diluted) is $-0.17 as of Mar. 2026. GuruFocus rates AIRDF with a GF Score™ of 29/100. The stock has 7 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Rocket Doctor AI ranks better than 74.66% on this metric.
Rocket Doctor AI's EPS (Basic) for the
three
months ended in Mar. 2026 was $-0.04.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.17.
During the past 3 years, the average EPS without NRIGrowth Rate was 31.10% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 32.40% per year.
During the past 7 years, Rocket Doctor AI's highest 3-Year average EPS without NRI Growth Rate was 58.80% per year. The lowest was -76.50% per year. And the median was 30.65% per year.
Rocket Doctor AI (OTCPK:AIRDF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Rocket Doctor AI Earnings per Share (Diluted) Related Terms
Rocket Doctor AI Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Rocket Doctor AI's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rocket Doctor AI Earnings per Share (Diluted) Chart
AIRDF vs VEEV, BTSG, TEM: Earnings per Share (Diluted) Comparison
For the Health Information Services subindustry, Rocket Doctor AI's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rocket Doctor AI PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rocket Doctor AI's PE Ratio distribution charts can be found below:
* The bar in red indicates where Rocket Doctor AI's PE Ratio falls into.
Rocket Doctor AI Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Rocket Doctor AI's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.17
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $-0.17 mean?
Rocket Doctor AI (AIRDF) has a Earnings per Share (Diluted) of $-0.17 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Rocket Doctor AI and its competitors. According to the industry distribution chart, Rocket Doctor AI ranks #129 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 25.3%.
Is Rocket Doctor AI's Earnings per Share (Diluted) too high?
Rocket Doctor AI's current Earnings per Share (Diluted) is $-0.17. Based on the distribution chart, Rocket Doctor AI ranks #129 out of 509 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Rocket Doctor AI has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's Earnings per Share (Diluted) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Rocket Doctor AI ranks #129 out of 509 companies for Earnings per Share (Diluted). This puts Rocket Doctor AI in the upper half of its industry. The industry median Earnings per Share (Diluted) is 11.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.50, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Rocket Doctor AI and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rocket Doctor AI's current Earnings per Share (Diluted) is $-0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current Earnings per Share (Diluted) of $-0.17. The current Earnings per Share (Diluted) is $-0.17. Rocket Doctor AI's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current Earnings per Share (Diluted) is $-0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
29GF Score
Get the complete analysis for AIRDF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRDF has been successfully added to your 
